Left cingulate lesion on FLAIR sequence before treatment
[1] Postal M, Lapa AT, Reis F, Rittner L, Appenzeller S. (2017) Magnetic resonance imaging in neuropsychiatric systemic lupus erythematosus: current state of the art and novel approaches. Lupus Apr;26(5):517-21 (PMID: 28394232)
[2] Hanly JG. (2014) Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol Jun;10(6):338-47. (PMID: 24514913)
[3] Sarbu N, Bargallo N, Cervera R. (2015) Advanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric Lupus. F1000Research 4:162. (PMID: 26236469)
[4] Sarbu N, Alobeidi F, Toledano P, Espinosa G, Giles I, Rahman A, et al. (2015) Brain abnormalities in newly diagnosed neuropsychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev Feb;14(2):153-9. (PMID: 25461835)
[5] Barile-Fabris L. (2005) Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis Apr 1;64(4):620-5. (PMID: 15769918)
[6] Ramos PC, Mendez MJ, Ames PR, Khamashta MA, Hughes GR. (1996) Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol Jun;14(3):295-9. (PMID: 8809444)
URL: | https://www.eurorad.org/case/15747 |
DOI: | 10.1594/EURORAD/CASE.15747 |
ISSN: | 1563-4086 |
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.